In addition, meta-analysis of published research investigating the association of IGF-1–IGF-2 and their binding proteins IGFBP-1–6 with prostate cancer confirmed that elevated circulating level of IGF-1 positively correlates with higher prostate cancer risk (281). This evidence concerns the gene IGF1 and prostate carcinoma.